Skip to content

Research stocks, funds and crypto by ticker or name

Loading

Portside

One living portfolio for stocks, ETFs, options, and crypto.

Product

Portfolio Intelligence Portside Congress trades Super-investors Economic calendar Earnings calendar Pricing

Company

About FAQs Contact Create account

Legal

Privacy Terms Portside rules

© 2026 InstaportInformation and analytics, not investment advice. Connections are read-only.

MCTA

Charming Medical Ltd

COMMON STOCK · NASDAQ

Price and daily changeSign in

52-week rangeSign inDay rangeSign in

Market cap

Loading evidence for MCTA

Sign in

Volume

Beta

Shares float

Short interest

3.35%

P/E (fwd)

PEG (fwd)

Rev growth (fwd)

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Create free account

Overview Statistics Statements Dividends🔒Momentum🔒Quant🔒Fair Value🔒Earnings Analysts🔒Insiders Smart Money Options🔒Insights🔒

Trading information

Beta: Sign in
Shares outstandingAs of 2026-03-31 · 2 filed common classes summed: 17.17M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 3.35%
Short ratioDays to cover, as published by FINRA: 999.99
Short volume (5D): —
Short volume (20D): —
Avg volume (10D): Sign in
Avg volume (3 months)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Sign in

Profitability

Gross marginFY Mar 26: 182.26%
Operating marginFY Mar 26: -1.12%
Net margin: —
EBITDA marginFY Mar 26: 7.14%
Return on equityNet income (FY Mar 26) ÷ average shareholders equity: -0.87%
Return on assetsNet income (FY Mar 26) ÷ average total assets: -0.30%

Growth

Revenue growth (annual YoY): -27.89%
Revenue growth (latest qtr YoY): —
Revenue growth (fwd): Sign in
Net income growth (annual YoY)FY Mar 26 vs FY Mar 25: -101.89%
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, FY Mar 26

0.00

EPS (fwd)

Financial health

Cash & equivalentsas of Mar 26: $4.69M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Mar 26: $185.79K
Debt / equityas of Mar 26: 3.59%
Current ratioas of Mar 26: 1.89
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Mar 26: 1.25
Operating cash flowFY Mar 26: -$1.21M
Free cash flowUnadjusted FCF = CFO − capex · FY Mar 26: -$1.55M
TTM revenue / diluted shareDiluted, FY Mar 26: 0.16

MCTA stock Statistics — Charming Medical Ltd filings, insiders & smart money · Instaport